Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease

ObjectiveHyperferritinaemia is associated with liver fibrosis severity in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), but the longitudinal implications have not been thoroughly investigated. We assessed the role of serum ferritin in predicting long-term outcomes o...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Gut 2024-01, Vol.73 (5), p.825-834
Hauptverfasser:	Armandi, Angelo, Sanavia, Tiziana, Younes, Ramy, Caviglia, Gian Paolo, Rosso, Chiara, Govaere, Olivier, Liguori, Antonio, Francione, Paolo, Gallego-Duràn, Rocìo, Ampuero, Javier, Pennisi, Grazia, Aller, Rocio, Tiniakos, Dina, Burt, Alastair, David, Ezio, Vecchio, Fabio, Maggioni, Marco, Cabibi, Daniela, McLeod, Duncan, Pareja, Maria Jesus, Zaki, Marco Y W, Grieco, Antonio, Stål, Per, Kechagias, Stergios, Fracanzani, Anna Ludovica, Valenti, Luca, Miele, Luca, Fariselli, Piero, Eslam, Mohammed, Petta, Salvatore, Hagström, Hannes, George, Jacob, Schattenberg, Jörn M, Romero-Gómez, Manuel, Anstee, Quentin Mark, Bugianesi, Elisabetta
Format:	Artikel
Sprache:	eng
Schlagworte:	Body mass index Fatty liver Ferritin FIBROSIS Hepatocellular carcinoma Hepatology Liver cancer Liver diseases Medicin och hälsovetenskap Mortality NONALCOHOLIC STEATOHEPATITIS Prediction models Risk assessment Womens health
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!